To summarize, we have successfully established a distinctive serum three-lncRNA signature (MALAT1, AFAP1-AS1 and AL359062) for NPC detection through stringent step-by-step selection procedures. This evidence concerns the gene AFAP1 and nasopharyngeal carcinoma.